Cross-Pipeline Analytics
The Cross-Pipeline Analytics page is designed to provide a high-level comparative view of research and development efforts over time and across different pipelines. It allows users to track how candidates progress through the R&D cycle and compare the maturity of different disease portfolios with each other.
Cross-pipeline analytics
The total volume of the R&D pipeline across the IGH measurement years. Use the filter to zoom into how the pipeline of one disease changed over time and see if the total number of candidates and approved products is increasing year-over-year.
Temporal trends & portfolio comparison
Track how candidates progress through the R&D cycle over time and compare the maturity of different disease portfolios with each other.
Compare how a single portfolio evolved over measurement years. Use the filters above to narrow down to specific diseases, products, or a single year.
Temporal trends in portfolio composition across R&D stages
Explore the temporal trends in a single portfolio, showing how distributions across R&D stages change over time. Filter by disease and product, and use the R&D stage legend and year controls to include or exclude specific stages and IGH review years for more focused analysis.
Temporal trends in aggregated R&D stages
Explore the temporal trends in a single portfolio with R&D stages aggregated into early development, late development, and approved products. Each cluster represents an aggregated R&D stage across IGH review years, showing how the portfolio shifts over time at a higher level than the granular stage view above.
Temporal trends in aggregated R&D stages – table view
Explore the underlying data for aggregated R&D stages, including year-on-year changes and total growth in portfolio composition over time.
12/12/24
Tracking global health investments: discover G-FINDER's impact
G-FINDER is the gold-standard tracker of R&D funding for new products and technologies for global health. Updated annually, this is the evidence base informing all global health advocacy, investment and policy change.
The case for change: Explore funding trends over time, where there is innovation and where there are gaps.
Drivers of impact: Understand which initiatives are gaining strength and where there are weaknesses in global health R&D impact.